Azenta (AZTA) Income from Discontinued Operations (2012 - 2024)
Azenta's (AZTA) quarterly Income from Discontinued Operations came in at 819000.0 in Q4 2024, up 49.13% year-on-year from 549183.67 in Q1 2024, and up 49.13% on a QoQ basis from 1610000.0 in Q4 2023.
Azenta (AZTA) Income from Discontinued Operations (2012 - 2024) Analysis & Trends
Azenta (AZTA) has 8 years of Income from Discontinued Operations data on file, last reported at 819000.0 in Q4 2024.
- On a quarterly basis, Income from Discontinued Operations rose 49.13% year-over-year to 819000.0 in Q4 2024; TTM through Dec 2024 was 15544000.0, a 96.68% decrease from a year earlier, with the FY2022 full-year figure at 480673000.0, up 1259.48% from the prior year.
- Income from Discontinued Operations for Q4 2024 stood at 819000.0, up from 1610000.0 in the prior quarter.
- Over the last five years, Income from Discontinued Operations for AZTA reached as high as 451860000.0 in Q1 2022 and fell as low as 1610000.0 in Q4 2023.
- Historically, Income from Discontinued Operations has averaged 51360100.0 across 5 years, with a median of 9394500.0 in 2021.
- On a YoY basis, Income from Discontinued Operations climbed as much as 5120.8% in 2022 and fell as far as 89.29% in 2022.
- Year by year, Income from Discontinued Operations stood at 6012000.0 in 2020, then jumped by 80.31% to 10840000.0 in 2021, then surged by 55.79% to 16888000.0 in 2022, then sank by 109.53% to 1610000.0 in 2023, then jumped by 49.13% to 819000.0 in 2024.
- Per Business Quant data, the three most recent Income from Discontinued Operations figures were 819000.0 in Q4 2024, 1610000.0 in Q4 2023, and 16888000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.15 Bn | 120.94 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.73 Bn | 43.91 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.91 Bn | 31.25 Bn | 1.53 Bn | - |
| 4 | Medline | 32.79 Bn | 30.55 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.52 Bn | 23.08 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.04 Bn | 13.47 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | - |
| 10 | Azenta | 1.28 Bn | 1.04 Bn | 125.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -819,000.00 |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2022 | 16.89 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 451.86 Mn |
| Dec 31, 2021 | 10.84 Mn |
| Sep 30, 2021 | 10.56 Mn |
| Jun 30, 2021 | 10.13 Mn |
| Mar 31, 2021 | 8.66 Mn |
| Dec 31, 2020 | 6.01 Mn |
| Mar 31, 2014 | 907,000.00 |
| Dec 31, 2013 | 907,000.00 |
| Sep 30, 2013 | -2.18 Mn |
| Mar 31, 2013 | -456,000.00 |
| Dec 31, 2012 | 216,000.00 |